Hot Investor Mandate: Healthcare Foundation Opens Evergreen Fund to Invest in Early Stage Oncology

13 Dec

A healthcare foundation has created a new $150M evergreen fund, and is looking to make 3-4 investments a year. The foundation is interested in therapeutics, diagnostics or screening technology, medical devices, digital health or tech enabled services that advance the fight against cancer. The firm is looking to help these technologies advance to commercialization, investing in IND-ready/clinical stage companies, or post-revenue-generating digital health companies. For earlier stage companies, The firm will invest between $250K-1M, and will invest $3-6M in later stage companies, reserving funds for follow-on investments. The firm is currently looking to co-invest, and will consider global opportunities, but is currently investing mostly in the US

While relatively agnostic to technology within therapeutics, medical devices, diagnostics and digital health, the firm will only invest in companies relevant to the indication of oncology.

The firm is looking for therapeutics companies that are out of Phase I, but will invest in companies as early as IND-ready. For medical device companies, the firm prefers them to be clinical stage. For digital health companies, the firm will consider companies that have >$1M in annual revenues. Currently, the firm is looking to co-invest, but will refer potential portfolio companies to their investment partners for consideration.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: